Advisor-Teller Money manager (ATM) therapy for substance use disorders

Psychiatric Services

Volumn 61, Issue 7, 2010, Pages 707-713

  Rosen, Marc I ^a,b   Rounsaville, Bruce J ^a   Ablondi, Karen ^a   Black, Anne C ^a   Rosenheck, Robert A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVISOR TELLER MONEY MANAGER THERAPY; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ARTICLE; BUDGET; CLINICAL TRIAL; COCAINE DEPENDENCE; COMMUNITY MENTAL HEALTH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FINANCIAL MANAGEMENT; FUNDING; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT AUTONOMY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SUBSTANCE ABUSE; URINALYSIS; ECONOMICS; MIDDLE AGED; OUTCOME ASSESSMENT; PROCEDURES; SUBSTANCE-RELATED DISORDERS; UNITED STATES; URINE;

ADULT; BUDGETS; CONNECTICUT; FEMALE; FINANCING, PERSONAL; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SUBSTANCE-RELATED DISORDERS;

EID: 85047683232     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2010.61.7.707     Document Type: Article

References (36)

1. Dixon L: Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research 35(suppl): S93-S100, 1999 (Pubitemid 29133030)
2. Kessler RC, Crum RM, Warner LA, et al: Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 54:313-321, 1997
3. Rosen MI, Rosenheck RA, Shaner A, et al: Veterans who may need a payee to prevent misuse of funds for drugs. Psychiatric Services 53:995-1000, 2002 (Pubitemid 34816093)
4. Evans JD, Wright DE, Svanum S, et al: Psychiatric disorder and unmet service needs among welfare clients in a representative payee program. Community Mental Health Journal 40:539-548, 2004 (Pubitemid 39524435)
5. Shaner A, Eckman TA, Roberts LJ, et al: Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers: a government-sponsored revolving door. New England Journal of Medicine 333:777-783, 1995
6. Thaler RH: Mental accounting matters. Journal of Behavioral Decision Making 12:183-206, 1999
7. Thaler RH, Sunstein CR: Nudge: Improving Decisions About Health, Wealth and Happiness. New Haven, Yale University Press, 2008
8. Thaler RH, Shefrin HM: An economic theory of self-control. Journal of Political Economy 39:392-406, 1981
9. Rosen MI, Carroll KM, Stefanovics E, et al: A randomized controlled trial of a money management-based substance use intervention. Psychiatric Services 60:498-504, 2009
10. Lehman AF, Dixon LB, Kernan E, et al: A randomized trial of assertive community treatment for homeless persons with severe mental illness. Archives of General Psychiatry 54:1038-1043, 1997 (Pubitemid 27476100)
11. Conrad KJ, Matters MD, Hanrahan P, et al: Characteristics of persons with mental illness in a representative payee program. Psychiatric Services 49:1223-1225, 1998 (Pubitemid 28414690)
12. Rosen MI, McMahon TJ, Rosenheck R: Does assigning a representative payee reduce substance abuse? Drug and Alcohol Dependence 86:115-122, 2007
13. Ries RK, Comtois KA: Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders: a comparative study of payee and non-payee participants. American Journal on Addictions 6:330-338, 1997
14. Conrad KJ, Lutz G, Matters MD: Randomized trial of psychiatric care with representative payeeship for persons with serious mental illness. Psychiatric Services 57:197-204, 2006 (Pubitemid 43214465)
15. Swartz JA, Hsieh CM, Baumohl J: Disability payments, drug use and representative payees: an analysis of the relationships. Addiction 98:965-975, 2003
16. Stout RL, Wirtz PW, Carbonari JP, et al: Ensuring balanced distribution of prognostic factors in treatment outcome research. Journal of Studies on Alcohol Supplement 12:70-75, 1994
17. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for the DSMIV Axis I Disorders - Patient Edition (SCID-I/P Version 2.0). New York, New York State Psychiatric Institute, Biometrics Research Department, 1996
18. McLellan AT, Kushner H, Metzger D, et al: The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9:199-213, 1992
19. Sacks JA, Drake RE, Williams VF, et al: Utility of the time-line follow-back to assess substance use among homeless adults. Journal of Nervous and Mental Disease 191:145-153, 2003
20. Rosenberg SD, Drake RE, Wolford GL, et al: Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. American Journal of Psychiatry 155:232-238, 1998 (Pubitemid 28074286)
21. Derogatis LR: Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual, 2nd ed. Baltimore, Clinical Psychometric Research, 1992
22. Raudenbush SW, Bryk AS, Cheong YF, et al: HLM 6: Hierarchical Linear and Non-linear Modeling. Lincolnwood, Ill, SSI, 2004
23. Raudenbush SW, Xiao-Feng L: Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychological Methods 4:387-401, 2001
24. Bellack AS, Bennett ME, Gearon JS, et al: A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry 63:426-432, 2006
25. Drake RE, O'Neal EL, Wallach MA, et al: A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment 34:123-138, 2008
26. Brunette MF, Mueser KT, Drake RE, et al: A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug and Alcohol Review 23:471-481, 2004 (Pubitemid 40019755)
27. Essock SM, Mueser KT, Drake RE, et al: Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services 57:185-196, 2006
28. Drebing CE, Van Ormer EA, Krebs C, et al: The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans. Journal of Applied Behavior Analysis 38:359-372, 2005 (Pubitemid 43592186)
29. Shaner A, Khalsa ME, Roberts L, et al: Unrecognized cocaine use among schizophrenic patients. American Journal of Psychiatry 150:758-762, 1993 (Pubitemid 23137682)
30. Bennett ME, Bellack AS, Gearon JS, et al: Development of a comprehensive measure to assess clinical issues in dual diagnosis patients: the Substance Use Event Survey for Severe Mental Illness. Addictive Behaviors 31:2249-2267, 2006
31. Elbogen EB, Swanson JW, Swartz MS, et al: Family representative payeeship and violence risk in severe mental illness. Law and Human Behavior 29:563-574, 2005 (Pubitemid 44257260)
32. Estroff SE, Swanson JW, Lachicotte WS, et al: Risk reconsidered: targets of violence in the social networks of people with serious psychiatric disorders. Social Psychiatry and Psychiatric Epidemiology 33(suppl 1):S95-S101, 1998
33. Angell B, Martinez NI, Mahoney CA, et al: Payeeship, financial leverage, and the client-provider relationship. Psychiatric Services 58:365-372, 2007 (Pubitemid 46480053)
34. Hanrahan P, Luchins DJ, Savage C, et al: Representative payee programs for persons with mental illness in Illinois. Psychiatric Services 53:190-194, 2002 (Pubitemid 34111498)
35. Ziedonis DM, Smelson D, Rosenthal RN, et al: Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. Journal of Psychiatric Practice 11:315-339, 2005 (Pubitemid 41540226)
36. Tsemberis S, Gulcur L, Nakae M: Housing first, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. American Journal of Public Health 94:651-656, 2004 (Pubitemid 38436512)